+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Juno Therapeutics Inc (JUNO) - Financial and Strategic SWOT Analysis Review


  • ImmuneXcite Inc
  • NeoGenomics Inc
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Juno Therapeutics Inc (Juno) is a clinical-stage company that develops novel cellular immunotherapies. The company formulates cell-based cancer immunotherapies based on platforms such as chimeric antigen receptor and high-affinity T cell receptor technologies to genetically engineer T cells to identify and kill cancer cells. It develops CD19 CAR and WT-1 TCR clinical programs which include numerous product candidates in clinical development for several hematologic malignancies in adults and children. Juno offers CAR and TCR product candidates targeting multiple cancer types. The company works in collaboration with various cancer centers. Juno is headquartered in Seattle, Washington, the US.

Juno Therapeutics Inc Key Recent Developments

Jan 12, 2018: Juno Therapeutics Investigation By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Juno Therapeutics, Inc. - JUNO
Jan 05, 2018: Juno Therapeutics Names Cindy Elkins as Chief Information Officer
Dec 20, 2017: Juno Therapeutics and Thermo Fisher Scientific Announce CAR T Manufacturing Partnership
Nov 27, 2017: Juno Therapeutics Appoints Ann L. Lee as Executive Vice President of Technical Operations and Patrick Y. Yang as Executive Vice President, Senior Advisor to the CEO
Nov 01, 2017: Juno Therapeutics Reports Third Quarter 2017 Financial Results

This comprehensive SWOT profile of Juno Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Juno Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown


  • ImmuneXcite Inc
  • NeoGenomics Inc
  • MORE
Section 1 - About the Company
  • Juno Therapeutics Inc - Key Information
  • Juno Therapeutics Inc - Overview
  • Juno Therapeutics Inc - Key Employees
  • Juno Therapeutics Inc - Key Employee Biographies
  • Juno Therapeutics Inc - Key Operational Heads
  • Juno Therapeutics Inc - Major Products and Services
  • Juno Therapeutics Inc - History
  • Juno Therapeutics Inc - Company Statement
  • Juno Therapeutics Inc - Locations And Subsidiaries
  • Juno Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Juno Therapeutics Inc - Business Description
  • Juno Therapeutics Inc - Corporate Strategy
  • Juno Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Juno Therapeutics Inc - Strengths
  • Juno Therapeutics Inc - Weaknesses
  • Juno Therapeutics Inc - Opportunities
  • Juno Therapeutics Inc - Threats
  • Juno Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Juno Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Juno Therapeutics Inc, Key Information
  • Juno Therapeutics Inc, Key Ratios
  • Juno Therapeutics Inc, Share Data
  • Juno Therapeutics Inc, Major Products and Services
  • Juno Therapeutics Inc, History
  • Juno Therapeutics Inc, Key Employees
  • Juno Therapeutics Inc, Key Employee Biographies
  • Juno Therapeutics Inc, Key Operational Heads
  • Juno Therapeutics Inc, Other Locations
  • Juno Therapeutics Inc, Subsidiaries
  • Juno Therapeutics Inc, Key Manufacturing facilities
  • Juno Therapeutics Inc, Key Competitors
  • Juno Therapeutics Inc, SWOT Analysis
  • Juno Therapeutics Inc, Ratios based on current share price
  • Juno Therapeutics Inc, Annual Ratios
  • Juno Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Juno Therapeutics Inc, Performance Chart
  • Juno Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown


  • Tragara Pharmaceuticals Inc
  • Novartis Pharmaceuticals Corp
  • NeoGenomics Inc
  • ImmuneXcite Inc
  • Eiger BioPharmaceuticals Inc
Note: Product cover images may vary from those shown